Ovid Therapeutics (OVID) Treasury Shares (2025 - 2026)

Ovid Therapeutics (OVID) reported Treasury Shares of $669545.0 for Q1 2026, up 95.8% quarter-over-quarter from $341955.0 in Q3 2025.

Ovid Therapeutics (OVID) Treasury Shares (2025 - 2026) Analysis & Trends

Ovid Therapeutics has reported Treasury Shares for 2 years, with the latest figure at $669545.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	700,000.00
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Ovid Therapeutics	311.83 Mn	156.31 Mn	-	669,545.00

Download Data